Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-29

Clinical Trial Update: Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dosing regimens of acetazolamide for prevention of acute mountain sickness has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Utah | Conditions: Prophylaxis of Acute Mountain Sickness | Phase 4 | Status: COMPLETED | Results posted: 2019-01-29